144 related articles for article (PubMed ID: 33623898)
1. Prognostic Impact of Sphingosine Kinase 1 in Nonsmall Cell Lung Cancer.
Motono N; Ueda Y; Shimasaki M; Iwai S; Iijima Y; Usuda K; Uramoto H
Clin Pathol; 2021; 14():2632010X20988531. PubMed ID: 33623898
[TBL] [Abstract][Full Text] [Related]
2. Expression of Sphingosine Kinase-1 Is Associated with Invasiveness and Poor Prognosis of Oral Squamous Cell Carcinoma.
Kato K; Shimasaki M; Kato T; Segami N; Ueda Y
Anticancer Res; 2018 Mar; 38(3):1361-1368. PubMed ID: 29491060
[TBL] [Abstract][Full Text] [Related]
3. Microarray analysis of altered sphingolipid metabolism reveals prognostic significance of sphingosine kinase 1 in breast cancer.
Ruckhäberle E; Rody A; Engels K; Gaetje R; von Minckwitz G; Schiffmann S; Grösch S; Geisslinger G; Holtrich U; Karn T; Kaufmann M
Breast Cancer Res Treat; 2008 Nov; 112(1):41-52. PubMed ID: 18058224
[TBL] [Abstract][Full Text] [Related]
4. Sphingosine-1-phosphate/sphingosine kinase 1-dependent lymph node metastasis in esophageal squamous cell carcinoma.
Kawakita Y; Motoyama S; Sato Y; Koyota S; Wakita A; Liu J; Saito H; Minamiya Y
Surg Today; 2017 Nov; 47(11):1312-1320. PubMed ID: 28364399
[TBL] [Abstract][Full Text] [Related]
5. Sphingosine kinase-1 predicts overall survival outcomes in non-small cell lung cancer patients treated with carboplatin and navelbine.
Gachechiladze M; Tichý T; Kolek V; Grygárková I; Klein J; Mgebrishvili G; Kharaishvili G; Janíková M; Smičková P; Cierna L; Pitson S; Maddelein ML; Cuvillier O; Škarda J
Oncol Lett; 2019 Aug; 18(2):1259-1266. PubMed ID: 31423186
[TBL] [Abstract][Full Text] [Related]
6. Epithelial-Mesenchymal Transition in Non Small-cell Lung Cancer.
Tsoukalas N; Aravantinou-Fatorou E; Tolia M; Giaginis C; Galanopoulos M; Kiakou M; Kostakis ID; Dana E; Vamvakaris I; Korogiannos A; Tsiambas E; Salemis N; Kyrgias G; Karameris A; Theocharis S
Anticancer Res; 2017 Apr; 37(4):1773-1778. PubMed ID: 28373440
[TBL] [Abstract][Full Text] [Related]
7. Predictive and prognostic value of sphingosine kinase 1 expression in patients with invasive ductal carcinoma of the breast.
Do SI; Kim HS; Kim K; Lee H; Do IG; Kim DH; Chae SW; Sohn JH
Am J Transl Res; 2017; 9(12):5684-5695. PubMed ID: 29312521
[TBL] [Abstract][Full Text] [Related]
8. Prognostic implications of neuroendocrine differentiation and hormone production in patients with Stage I nonsmall cell lung carcinoma.
Pelosi G; Pasini F; Sonzogni A; Maffini F; Maisonneuve P; Iannucci A; Terzi A; De Manzoni G; Bresaola E; Viale G
Cancer; 2003 May; 97(10):2487-97. PubMed ID: 12733148
[TBL] [Abstract][Full Text] [Related]
9. Non-Small-cell Lung Cancer Patients With Adenocarcinoma Morphology Have a Better Outcome Compared With Patients Diagnosed With Non-Small-cell Lung Cancer Favor Adenocarcinoma.
Shiran I; Heller E; Jessel S; Kamer I; Daniel-Meshulam I; Navon R; Urban D; Onn A; Bar J
Clin Lung Cancer; 2017 May; 18(3):316-323.e1. PubMed ID: 28237243
[TBL] [Abstract][Full Text] [Related]
10. LncRNA HULC promotes non-small cell lung cancer cell proliferation and inhibits the apoptosis by up-regulating sphingosine kinase 1 (SPHK1) and its downstream PI3K/Akt pathway.
Liu L; Zhou XY; Zhang JQ; Wang GG; He J; Chen YY; Huang C; Li L; Li SQ
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8722-8730. PubMed ID: 30575912
[TBL] [Abstract][Full Text] [Related]
11. Targeting the SphK1/S1P/S1PR1 Axis That Links Obesity, Chronic Inflammation, and Breast Cancer Metastasis.
Nagahashi M; Yamada A; Katsuta E; Aoyagi T; Huang WC; Terracina KP; Hait NC; Allegood JC; Tsuchida J; Yuza K; Nakajima M; Abe M; Sakimura K; Milstien S; Wakai T; Spiegel S; Takabe K
Cancer Res; 2018 Apr; 78(7):1713-1725. PubMed ID: 29351902
[TBL] [Abstract][Full Text] [Related]
12. Increased radiation sensitivity of head and neck squamous cell carcinoma with sphingosine kinase 1 inhibition.
Sinha UK; Schorn VJ; Hochstim C; Chinn SB; Zhu S; Masood R
Head Neck; 2011 Feb; 33(2):178-88. PubMed ID: 20848438
[TBL] [Abstract][Full Text] [Related]
13. Bax, bcl-2 and c-kit expression in non-small-cell lung cancer and their effects on prognosis.
Yaren A; Oztop I; Kargi A; Ulukus C; Onen A; Sanli A; Binicier O; Yilmaz U; Alakavuklar M
Int J Clin Pract; 2006 Jun; 60(6):675-82. PubMed ID: 16805752
[TBL] [Abstract][Full Text] [Related]
14. SPHK1 promotes metastasis of thyroid carcinoma through activation of the S1P/S1PR3/Notch signaling pathway.
Zhao Z; Ma J; Hu B; Zhang Y; Wang S
Exp Ther Med; 2018 Jun; 15(6):5007-5016. PubMed ID: 29805524
[TBL] [Abstract][Full Text] [Related]
15. Sphingosine kinase 1: A novel independent prognosis biomarker in hepatocellular carcinoma.
Cai H; Xie X; Ji L; Ruan X; Zheng Z
Oncol Lett; 2017 Apr; 13(4):2316-2322. PubMed ID: 28454397
[TBL] [Abstract][Full Text] [Related]
16. Altered retinoblastoma protein expression in nonsmall cell lung cancer: its synergistic effects with altered ras and p53 protein status on prognosis.
Dosaka-Akita H; Hu SX; Fujino M; Harada M; Kinoshita I; Xu HJ; Kuzumaki N; Kawakami Y; Benedict WF
Cancer; 1997 Apr; 79(7):1329-37. PubMed ID: 9083154
[TBL] [Abstract][Full Text] [Related]
17. Triple Negative Breast Cancer Depends on Sphingosine Kinase 1 (SphK1)/Sphingosine-1-Phosphate (S1P)/Sphingosine 1-Phosphate Receptor 3 (S1PR3)/Notch Signaling for Metastasis.
Wang S; Liang Y; Chang W; Hu B; Zhang Y
Med Sci Monit; 2018 Apr; 24():1912-1923. PubMed ID: 29605826
[TBL] [Abstract][Full Text] [Related]
18. Subtyping of nonsmall cell lung cancer on cytology specimens: reproducibility of cytopathologic diagnoses on sparse material.
Omland SH; Henrik H; Olsen EK; Birthe T; Guldhammer SB
Diagn Cytopathol; 2014 Feb; 42(2):105-10. PubMed ID: 23687077
[TBL] [Abstract][Full Text] [Related]
19. Sphingosine kinase 1 is a reliable prognostic factor and a novel therapeutic target for uterine cervical cancer.
Kim HS; Yoon G; Ryu JY; Cho YJ; Choi JJ; Lee YY; Kim TJ; Choi CH; Song SY; Kim BG; Bae DS; Lee JW
Oncotarget; 2015 Sep; 6(29):26746-56. PubMed ID: 26311741
[TBL] [Abstract][Full Text] [Related]
20. FAM83B is a novel biomarker for diagnosis and prognosis of lung squamous cell carcinoma.
Okabe N; Ezaki J; Yamaura T; Muto S; Osugi J; Tamura H; Imai J; Ito E; Yanagisawa Y; Honma R; Gotoh M; Watanabe S; Waguri S; Suzuki H
Int J Oncol; 2015 Mar; 46(3):999-1006. PubMed ID: 25586059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
